Nektar Therapeutics (NKTR)

Finanzdaten der Nektar Therapeutics-Aktie (NKTR)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	9.40% 21.64	23.89	24.14	20.50	21.59
Cost Of Revenue	17.18% 8.534	7.283	12.43	6.994	7.06
Gross Profit	21.06% 13.11	16.60	11.71	13.51	14.53
Operating Expenses	3.15% 48.53	50.11	56.58	64.10	149.24
Benefits Costs and Expenses	11.39% 58.48	65.99	70.04	71.67	158.68
Costs And Expenses	0.57% 57.07	57.40	69.01	71.10	156.30
Depreciation and Amortization	2.72% 1.607	1.652	1.695	2.166	2.302
Operating Income/Loss	5.72% -35.43	-33.51	-44.86	-50.60	-134.71
Nonoperating Income/Loss	83.60% -1.41	-8.597	-1.034	-0.57	-2.371
Income/Loss From Continuing Operations Before Tax	12.52% -36.84	-42.11	-45.90	-51.17	-137.08
Income Tax Expense/Benefit, Deferred	102.22% -0.038	1.714	-0.015	-0.027	-1.812
Income Tax Expense/Benefit	20.69% -0.035	-0.029	-0.061	-0.047	-0.063
Income/Loss From Continuing Operations After Tax	12.54% -36.80	-42.08	-45.84	-51.12	-137.02
Net Income/Loss	12.54% -36.80	-42.08	-45.84	-51.12	-137.02
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	55,542% 194.75	0.35	190.41	189.66	188.88
Diluted Average Shares	55,542% 194.75	0.35	190.41	189.66	188.88
Basic Earnings Per Share	13.64% -0.19	-0.22	-0.24	-0.27	-0.73
Diluted Earnings Per Share	13.64% -0.19	-0.22	-0.24	-0.27	-0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-